|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00775 CKLIFE SCIENCES
Nominal 
0.540 -0.015 (-2.703%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 2,715,761 | 4.219% | 5,410,228 | 5,522,674 | 5,322,733 | 5,275,590 |
| Cost of Sales | (1,951,222) | 7.672% | (3,833,314) | (3,830,119) | (3,685,525) | (3,649,604) |
| Gross Profit | 764,539 | -3.664% | 1,576,914 | 1,692,555 | 1,637,208 | 1,625,986 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (218) | -- | 359 | 148 | 333 | 24 | |
| Profit / (Loss) before Taxation | (18,581) | -86.221% | (18,011) | (91,482) | 68,584 | 204,864 | |
| Taxation | (30,049) | 87.994% | (170,436) | (35,072) | (51,334) | (72,912) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 19,900 | -- | 1,641 | 0 | 0 | 11 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (28,730) | -80.953% | (186,806) | (126,554) | 17,250 | 131,963 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 123,948 | -6.672% | 245,690 | 323,289 | 309,246 | 157,317 |
| Depreciation & Amortisation | 44,725 | 4.036% | 245,316 | 245,158 | 233,741 | 230,914 |
| Directors' Emoluments | -- | -- | 39,155 | 33,619 | 25,957 | 25,588 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -0.300 | -80.892% | -1.940 | -1.320 | 0.180 | 1.370 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.800 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 58.394% |
| Cash flow per share ($) | -- | -- | 0.019 | 0.037 | 0.053 | 0.038 |
| NBV per share ($) | 0.411 | -- | 0.393 | 0.365 | 0.436 | 0.433 |
| Remarks: | Real time quote last updated: 13/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -28,730 |
| %Change | -80.953% |
| EPS / (LPS) | HKD -0.003 |
| NBV Per Share ($) | HKD 0.411 |